Mitochondrial trifunctional protein deficiency in human cultured fibroblasts: effects of bezafibrate. Issue 1 (25th June 2015)

• Record Type: Journal Article
• Authors: Djouadi, Fatima; Habarou, Florence; Le Bachelier, Carole; Ferdinandusse, Sacha; Schlemmer, Dimitri; Benoist, Jean François; Boutron, Audrey; Andresen, Brage S.; Visser, Gepke; de Lonlay, Pascale; Olpin, Simon; Fukao, Toshiyuki; Yamaguchi, Seiji; Strauss, Arnold W.; Wanders, Ronald J. A.; Bastin, Jean
• Is Part Of: Journal of inherited metabolic disease. Volume 39:Issue 1(2016)
• Page Start: 47
• Page End: 58
• Publication Date: 2015-06-25
• Subjects: Metabolism, Inborn errors of -- Periodicals; Metabolism -- Disorders -- Periodicals; 616.39042
• DOI: 10.1007/s10545-015-9871-3
• Languages: English
• ISSNs: 0141-8955

Abstract

Abstract: Mitochondrial trifunctional protein (MTP) deficiency caused by HADHA or HADHB gene mutations exhibits substantial molecular, biochemical, and clinical heterogeneity and ranks among the more severe fatty acid oxidation (FAO) disorders, without pharmacological treatment. Since bezafibrate has been shown to potentially correct other FAO disorders in patient cells, we analyzed its effects in 26 MTP‐deficient patient fibroblasts representing 16 genotypes. Overall, the patient cell lines exhibited variable, complex, biochemical profiles and pharmacological responses. HADHA‐deficient fibroblasts showed markedly reduced alpha subunit protein levels together with decreased beta‐subunit abundance, exhibited a −86 to −96 % defect in LCHAD activity, and produced large amounts of C14 and C16 hydroxyacylcarnitines. In control fibroblasts, exposure to bezafibrate (400 μM for 48 h) increased the abundance of HADHA and HADHB mRNAs, immune‐detectable alpha and beta subunit proteins, activities of LCHAD and LCKAT, and stimulated FAO capacities, clearly indicating that MTP is pharmacologically up‐regulated by bezafibrate in human fibroblasts. In MTP‐deficient patient fibroblasts, which were found markedly FAO‐deficient, bezafibrate improved FAO capacities in six of 26 (23 %) cases, including three cell lines heterozygous for the common c1528G > C mutation. Altogether, our results strongly suggest that, due to variable effects of HADHA and HADHB mutations on MTP abundance and residual activity, improvement of MTP deficiency in response to bezafibrate was achieved in a subset of responsive genotypes.